title: Participation in research: the economic advantages in a haemophilia research population.
authors.affiliation: The University of Texas Health Science Center at Houston, Houston, Texas, USA. jwasserman@ped1.med.uth.tmc.edu
authors.forename: J
authors.initials: J
authors.lastname: Wasserman
authors.forename: M
authors.initials: M
authors.lastname: Ullman
authors.forename: M
authors.initials: M
authors.lastname: Cantini
authors.forename: K
authors.initials: K
authors.lastname: Moynihan
authors.forename: W K
authors.initials: WK
authors.lastname: Hoots
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use; D002985:Clinical Protocols; D003363:Cost Control; D016527:Drug Costs; D005164:Factor IX / Q000191:economics / Q000627:therapeutic use; D005169:Factor VIII / Q000191:economics / Q000627:therapeutic use; D017048:Health Care Costs; D006467:Hemophilia A / Q000191:economics* / Q000821:virology; D002836:Hemophilia B / Q000191:economics / Q000821:virology; D006801:Humans; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use; D012106:Research / Q000191:economics*
chemical_list: D019380:Anti-HIV Agents; D011994:Recombinant Proteins; D005169:Factor VIII; D005164:Factor IX